InvestorsHub Logo

BIOChecker4

12/11/23 9:38 PM

#442307 RE: falconer66a #442306

Presumably Dr. Fadiran also signed on with full knowledge and expectation that full clinical data, when eventually released or presented to drug regulatory bodies would result in commercialization of the Anavex drug candidates.

Since he recently left the company, by your logic (and the logic of certain other WGTers), we must assume that on second thought he decided regulatory authorities would not approve Anavex drug candidates and the drugs would not be commercialized.

If Dr. Fadiran joined because he was sure Anavex drugs would be approved and commercialized, then the only logical conclusion is that he left because he had second thoughts.

Good licks and DOG bless,

ExtremelyBullishZig

12/11/23 10:17 PM

#442310 RE: falconer66a #442306

The issue is that you are trying too hard for this audience. This isn't a magazine...it is a virtual room full of hacks.